09.11.2015 • Topics

Life Sciences Sector Grows in Austria

© Maksym Yemelyanov - Fotolia.com
© Maksym Yemelyanov - Fotolia.com

Austria’s life science industry as well as its research institutions have established a fast growing sector. The latest Life Science Report Austria shows the sustained attractiveness of Austria as a life science location based on the close links between solid academic research and innovative companies as well as the broad offering of tailor-made financial aids.

The development of the sector between 2012 and 2014 is remarkable: compared to the last report, the number of companies active in biotechnology, pharma or in the medical device business has increased by 13.8%. Together, life science companies generated a total turnover of over €19.1 billion (+7.8% compared to 2012).

In 2014, a total of 55 institutions were active in the field of academic life science research and education in Austria. About 20,000 people were working in universities, universities of applied sciences and non-university research institutes. In 2014, Austria’s life science budget amounted to €1.44 billion. About 73% of the budget stems from institutional funding, whereas 27% represent third-party funds.

Company

LISA Life Science Austria

Walcherstraße 11A
1020 Vienna
Austria

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read